PeptideAmerica

Evidence topic

The human trial record

These reviews report what a compound's human record contains, measured rather than characterized. An absence is stated only where a search was run, described, and dated; a count is printed only with the denominator it came from.

Several of the answers here are zero, and the zeros are the finding. A compound sold on a mechanism described in rodents is a compound whose human record a reader is entitled to see counted.

2 reviews

  1. Has BPC-157 ever been tested in a human clinical trial?

    BPC-157: The Human Trial Record

    No. Searching the National Library of Medicine's index across three name variants in August 2026 returned 228 papers mentioning the compound and none indexed under the clinical-trial publication type.

    The human trial record · BPC-157 · 4 sources

  2. Why was DSIP the only peptide the July 2026 committee refused to recommend?

    DSIP: The Committee's Only Rejection

    The panel voted 6–7, with one abstention, against listing, and the record it was reading contains no identified gene, precursor protein, or receptor after nearly fifty years, alongside a human literature of a few small studies whose most recent entry dates from 1992.

    The regulatory record · The human trial record · DSIP · 5 sources

The record behind the reviews

A review argues from the ledger; the ledger itself is published as reference tables, and every molecule’s dated posture is in the molecule index. Terms of art are defined in the glossary.